Johnson & Johnson Seeks Permission To Study Covid Single Shot Vaccine On Kids Aged 12-17 In India

<p><strong>New Delhi:</strong> The American pharma company Johnson &amp; Johnson has moved an application to the Central Drugs Standard Control Organisation (CDSCO) seeking permission to conduct a study of COVID-19 single shot vaccine in India in adolescents aged 12 &ndash; 17 years.&nbsp;</p> <p>Earlier this month, Union Health Minister Mansukh Mandaviya informed that the Johnson and Johnson&rsquo;s single-dose Covid-19 vaccine was given approval for Emergency Use in India. &nbsp;</p> <p>"India expands its vaccine basket! Johnson and Johnson&rsquo;s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against," Mansukh Mandaviya said.&nbsp;</p> <p>The vaccine maker has claimed that its single-shot Covid-19 vaccine has shown promising signs of protection against the Delta variant rapidly spreading across the US and other countries.&nbsp;</p> <p>The Drug Controller General of India earlier this year in May permitted Bharat Biotech to conduct clinical trials on healthy volunteers between 2 to 18 years of age for its vaccine, Covaxin.&nbsp;Besides Bharat Biotech, Zydus Cadila, which is developing DNA vaccines, &nbsp;is also conducting its clinical trial for between the age group of 12 to 18 years.</p> <p><strong>India vaccine coverage</strong></p> <p>Meanwhile, India&rsquo;s Covid-19 vaccination coverage has achieved a significant milestone of over 50 crores (57,16,71,264) with more than 48 lakh (48,84,440) Vaccine Doses administered in last 24 hours.&nbsp;</p> <p>26,66,831 vaccine doses were administered as first dose and 6,01,437 vaccine doses given as second dose in the age group 18-44 years today. Cumulatively, 21,13,11,218 persons in the age group 18-44 years across 37 States/UTs have received their first dose and total 1,79,43,325 have received their second dose since the start of Phase-3 of the vaccination drive.</p>

from covid-19 https://ift.tt/3svuwVk